Home> Products> Inhibitors> GSK2110183-CAS 1047634-63-8
price inquiry for CAS:1047634-63-8, Product:GSK2110183

GSK2110183 CAS: 1047634-63-8

Category: Inhibitors
Product Name: GSK2110183
Cat No: I000262
CAS No: 1047634-63-8
Molecular Formula: C18H16Cl2F2N4OS
Molecular Weight: 445.31
Solubility: 10 mM in DMSO
Target: Akt
IC50: 0.08/2/2.6 nM(Akt1/Akt2/Akt3) [1]
CAS 1047634-63-8,GSK2110183
  • Description

GSK2110183 is an orally bioavailable, selective, ATP-competitive and potent pan-Akt inhibitor with IC50s of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively.
IC50 value: 0.08/2/2.6 nM(Akt1/Akt2/Akt3) [1]
Target: Akt
GSK2110183 showed concentration-dependent effect on multiple AKT substrate phosphorylation levels, including GSK3β, PRAS40, FOXO and Caspase 9 in BT474 (breast; ERBB2+, PIK3CA K111N) and LNCaP (prostate; PTEN null). Mice bearing BT474 breast tumor xenografts were dosed orally with either vehicle or GSK2110183 at 10, 30 or 100 mg/kg daily for 21 days which resulted in 8, 37 and 61% TGI, respectively. Similarly, mice treated with GSK2110183 at 10, 30 and 100 mg/kg resulted in 23, 37 and 97% TGI, respectively, of SKOV3 xenografts.

  • References


[1]. Dumble M, et al. Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor. PLoS One. 2014 Jun 30;9(6):e100880.


price inquiry for CAS:1047634-63-8, Product:GSK2110183